DSM resumes repurchase of shares to cover existing option plans

Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it intends to repurchase 2,500,000 ordinary shares, starting on 27 February 2014, in order to cover its commitments under existing management and personnel option plans. Based on the closing price of the DSM share on Euronext Amsterdam on 26 February 2014 this would be equivalent to approximately €120 million.

This share repurchase program is anticipated to continue into Q2 2014 and is the second and final part of a program to repurchase 5 million shares in total, which was announced in September 2013. On 21 January 2014 DSM concluded the first part of this program under which 2,500,000 ordinary shares were repurchased for a total consideration of €139 million.

DSM has signed a Discretionary Management Agreement with the bank that will execute the repurchase. The repurchase price will be based on the daily VWAP (Volume Weighted Average Price). Volumes to be repurchased will be on average 5% of the daily trading volume on Euronext Amsterdam, within a bandwidth of 2-8% per day.

In accordance with the present regulations DSM will inform the market about the progress made in the execution of this program through weekly press releases.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Or find us on:      

For more information:

DSM Corporate Communications Herman Betten
tel. +31 (0) 45 5782017    
e-mail media.relations@dsm.comDSM Investor Relations Dave Huizing
tel. +31 (0) 45 5782864
e-mail investor.relations@dsm.comPress release-pdf


This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire
HUG#1765052